PCAST Future Is Uncertain Under Clinton

Presidential science panel may have to change its ways -- if, that is, it continues to exist Science journalists who brought a federal lawsuit against the White House Office of Science and Technology Policy (OSTP) say the court action has resulted in an opening up of some meetings of the President's Council of Advisers on Science and Technology (PCAST) and release of documents detailing PCAST's operations. They say they hope the case also will serve to send a warning to other federal scienc

Written byBarton Reppert
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share


Presidential science panel may have to change its ways -- if, that is, it continues to exist
Science journalists who brought a federal lawsuit against the White House Office of Science and Technology Policy (OSTP) say the court action has resulted in an opening up of some meetings of the President's Council of Advisers on Science and Technology (PCAST) and release of documents detailing PCAST's operations.

They say they hope the case also will serve to send a warning to other federal science and technology advisory panels that closing of meetings to the press and public is likely to be challenged, unless it is done in compliance with provisions of the Federal Advisory Committee Act (FACA).

However, several outgoing members of PCAST, which was formed by the Bush administration in early 1990, have told The Scientist that they believe their most important contribution was not through open meetings or published ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies